Fidelity Select Medical Technology and Devices Portfolio (FSMEX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Fidelity Select Medical Technology and Devices Portfolio (FSMEX) is down 16.2% since the beginning of the year. FSMEX is currently trading at $44 per share. Investors who bought $1,000 worth of FSMEX shares 5 years ago would now be looking at an investment worth $967.

Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has returned -16.24% so far this year and -10.21% over the past 12 months. Over the last ten years, FSMEX has returned 9.65% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Apr 28, 1998, FSMEX's average daily return is +0.05%, while the average monthly return is +1.08%. At this rate, an investment would double in approximately 5.4 years.

Historically, 63% of months were positive and 37% were negative. The best month was Apr 2020 with a return of +14.5%, while the worst month was Oct 2008 at -18.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, FSMEX closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +10.8%, while the worst single day was Mar 16, 2020 at -11.9%.

Fidelity Select Medical Technology and Devices Portfolio has an annualized alpha of 6.92%, beta of 0.77, and R2 of 0.61 versus S&P 500 Index. Calculated based on daily prices since April 29, 1998.

• This fund participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (90.18%) than losses (66.95%) - typical of diversified or defensive assets.
• This fund generated an annualized alpha of 6.92% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.

FSMEX has an expense ratio of 0.68%, placing it in the medium range.

FSMEX ranks 1 for risk / return — in the bottom 1% of mutual funds on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and compare them to S&P 500 Index.

Fidelity Select Medical Technology and Devices Portfolio provided a 21.67% dividend yield over the last twelve months, with an annual payout of $9.53 per share.

The table displays the monthly dividend distributions for Fidelity Select Medical Technology and Devices Portfolio. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Fidelity Select Medical Technology and Devices Portfolio. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Fidelity Select Medical Technology and Devices Portfolio was 40.34%, occurring on Oct 30, 2023. The portfolio has not yet recovered.

The current Fidelity Select Medical Technology and Devices Portfolio drawdown is 21.56%.

The chart below shows the rolling one-month volatility.